Showing results (51-60 of 178) with videos related to
Sort By:
Pageof 18
The International Journal of Neuroscience|January 8, 2020
Cranial nerve palsies in patients with hematological malignancies: a case seriesLuca Diamanti, Giulia Berzero, Diego Franciotta, et al.Neuropathology : Official Journal of the Japanese Society of Neuropathology|April 4, 2008
Radiation-induced glioblastoma in a medulloblastoma patient: a case report with molecular featuresMarco Gessi, Emanuela Maderna, Sara Guzzetti, et al.Neuro-Oncology|March 24, 2010
Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironmentSerena Pellegatta, Pietro Luigi Poliani, Elena Stucchi, et al.Stem Cells Translational Medicine|August 15, 2015
Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma PatientsSara Nava, Daniela Lisini, Simona Pogliani, et al.Neuro-Oncology|May 25, 2007
Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1Ettore Salsano, Laura Croci, Emanuela Maderna, et al.Neuroimage. Clinical|September 26, 2021
Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodiesMaëlle Dade, Marine Giry, Giulia Berzero, et al.Journal of Neuro-Oncology|August 19, 2011
Expression profile of frizzled receptors in human medulloblastomasEttore Salsano, Rosina Paterra, Miriam Figus, et al.Plos One|March 29, 2014
Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecanDomenico Aquino, Anna Luisa Di Stefano, Alessandro Scotti, et al.Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|January 9, 2018
Episodic Memory Impairments in Primary Brain Tumor PatientsThomas Durand, Giulia Berzero, Flavie Bompaire, et al.Pharmaceutics|March 6, 2020
PGE2 Is Crucial for the Generation of FAST Whole- Tumor-Antigens Loaded Dendritic Cells Suitable for Immunotherapy in GlioblastomaSara Nava, Daniela Lisini, Simona Frigerio, et al.Pageof 18